New Brunswick, NJ, United States of America

Li Tao



 

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Li Tao**

Introduction

Li Tao is a prominent inventor based in New Brunswick, NJ, known for his contributions to the pharmaceutical industry. With five patents to his name, his work is instrumental in advancing treatment options for patients.

Latest Patents

Among Li Tao's notable inventions are two groundbreaking patents related to pharmaceutical formulations containing an SGLT2 inhibitor. These formulations are designed for oral use, available in capsules or tablets, and feature the active ingredient dapagliflozin or its propylene glycol hydrate. The formulations are specifically designed for immediate release, enhancing the efficacy and accessibility of this medication for patients.

Career Highlights

Li Tao has built a distinguished career, with significant roles at renowned companies such as Bristol-Myers Squibb Company and AstraZeneca AB. His expertise and innovative approach have contributed to the development of critical therapies in the pharmaceutical sector.

Collaborations

Throughout his career, Li Tao has collaborated with noteworthy professionals, including Dilbir S. Bindra and Mandar V. Dali. These partnerships highlight his commitment to advancing medical science through shared knowledge and innovation.

Conclusion

Li Tao's contributions to the field of pharmaceuticals underscore the importance of innovation in improving healthcare outcomes. With multiple patents, his work continues to influence the development of vital medications, benefitting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…